Evaluation of the patients diagnosed as idiopathic intracranial hypertension with and without papilledema visual pathways by analysis of visual evoked potential

Simple item page
dc.contributor.authorKisabay A.
dc.contributor.authorSelcuki D.
dc.contributor.authorZeybek S.
dc.contributor.authorBatum M.
dc.date.accessioned2024-07-22T08:06:49Z
dc.date.available2024-07-22T08:06:49Z
dc.date.issued2021
dc.description.abstractBackground Idiopathic intracranial hypertension (IIH) is a clinical syndrome characterized by increased intracranial pressure in the absence of clinical, laboratory, or radiological findings of space-occupying lesion in the cranium. Papilledema is found in majority of the patients with IIH while it is absent in only about 5–6% of the patients. Methods Our primary objective was to evaluate the patients with IIH with (n: 45) and without (n: 15) papilledema using cranial MRI and VEP analyses and to compare the obtained results. Diagnosis of IIH according to ICHD-3 criteria admitted to and followed in our clinic before receiving any treatment between 2008 and 2018 were reviewed retrospectively after obtaining approval from the Ethics Committee. Results There was no statistically significant difference between both groups’ ages (P: 0.494) while differences in lumbar puncture (LP) opening pressure and VAS were found to be statistically significant (p = 0.034, 0.001, respectively). In our VEP investigation, it was seen that latencies in the group without papilledema were seen to be closer to those in the control group (P latency: 0.706, P amplitude: 0.080). Increase in latency and decrease in amplitude were seen in the group with papilledema compared to the group without papilledema (p < 0.001). Conclusion In conclusion, alterations in the optic nerve may be detected with VEP investigation before the detection of papilledema through ophthalmoscopic examination in these patients. Thus, VEP investigation may be considered to have predictive value. VEP examination may be recommended in diagnosis and treatment and during follow-up periods. © 2020 Informa UK Limited, trading as Taylor & Francis Group.
dc.identifier.DOI-ID10.1080/00207454.2020.1736581
dc.identifier.issn00207454
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13716
dc.language.isoEnglish
dc.publisherTaylor and Francis Ltd.
dc.subjectAdult
dc.subjectBrain
dc.subjectEvoked Potentials, Visual
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectPapilledema
dc.subjectPseudotumor Cerebri
dc.subjectVisual Pathways
dc.subjectYoung Adult
dc.subjectacetazolamide
dc.subjectfurosemide
dc.subjecttopiramate
dc.subjectadult
dc.subjectArticle
dc.subjectcerebrospinal fluid pressure
dc.subjectcluster headache
dc.subjectcontrolled study
dc.subjecteye examination
dc.subjectfemale
dc.subjectfollow up
dc.subjecthospital admission
dc.subjecthuman
dc.subjectidiopathic intracranial hypertension
dc.subjectlumbar puncture
dc.subjectmagnetic resonance venography
dc.subjectmaintenance drug dose
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectnausea
dc.subjectnuclear magnetic resonance imaging
dc.subjectobese patient
dc.subjectpapilledema
dc.subjectphonophobia
dc.subjectphotophobia
dc.subjectphysical examination
dc.subjectpredictive value
dc.subjectretrospective study
dc.subjectsecondary headache
dc.subjecttension headache
dc.subjecttinnitus
dc.subjecttransformed migraine
dc.subjectvisual evoked potential
dc.subjectvomiting
dc.subjectbrain
dc.subjectbrain pseudotumor
dc.subjectcomplication
dc.subjectmiddle aged
dc.subjectpapilledema
dc.subjectpathophysiology
dc.subjectvisual evoked potential
dc.subjectvisual system
dc.subjectyoung adult
dc.titleEvaluation of the patients diagnosed as idiopathic intracranial hypertension with and without papilledema visual pathways by analysis of visual evoked potential
dc.typeArticle

Files

Collections

Scopus Koleksiyonu